# New Drug Targets for Rare Metabolic Disease Identified

> Researchers at the Icahn School of Medicine at Mount Sinai mapped the full structure of the AASS enzyme involved in lysine breakdown, published in Science Advances. The study identifies mechanisms that can control the enzyme's activity.

- Date: 2026-11-13 · published 2026-11-14T15:11:08.869Z
- Category: report · region Global · magnitude low
- Page: https://feedsoft.ai/events/99587-new-drug-targets-for-rare-metabolic-disease-identified
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

The work points toward substrate reduction therapy for glutaric aciduria type 1, a rare human metabolic disorder, and has no meaningful link to feed grain, oilseed or livestock supply or prices.

## Sources

- insideprecisionmedicine.com: https://www.insideprecisionmedicine.com/topics/translational-research/new-drug-targets-for-rare-metabolic-disease-identified/

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.